News Release

EARLY WARNING NEWS RELEASE

FOR GLOBAL 1 SOLUTIONS LLC AND NATIONAL BRACE INC.

The securities being offered have not been, nor will be, registered under the United States Securities Act of 1933, as
amended, and may not be offered or sold in the United States or to U.S. persons without registration or
applicable exemption from the registration requirement of such Act. This release does not constitute an offer for sale of such securities in the United States of America.

Two Major Shareholders
of Advanced Bioceuticals Limited Acquire Controlling Share-Positions Through an
Acquisition and Share Exchange.

The Directors of Global 1 Solutions
LLC (“GSL”) and National Brace Inc. (“NBI”), the companies which are equal
shareholders of Advanced Bioceuticals
Limited (“ABL”), have acquired 130,700,000 shares for each of GSL and
NBI from Nass Valley Gateway Ltd (“Nass
Valley”) for 100% of the outstanding shares of ABL pursuant to a Definitive Acquisition
And Share Exchange agreement (“DASE_Agr”) between ABL and Nass Valley
(“Transaction”).

Referring to Nass Valley’s News
Release dated March 13, 2019, the approved issuance of the combined total of 261,400,000
shares issued to GSL and NBI represents the total consideration for the
acquisition for 100% of ABL’s assets at a deemed share price of Can$ 0.1429 per
share.

Prior to this Transaction, neither GSL or NBI nor its
directors owned any of Nass Valley’s outstanding securities. As a result of the
Transaction, GSL and NBI own each 41.87% of the presently issued and
outstanding shares of Nass Valley which would represent 39.70% ownership for
each GSL and NBI in Nass Valley’s share capital on a fully diluted basis.

All 261,400,000
shares issued to GSL and NBI will be subject to an escrow agreement, a copy of
which is available under the profile of the Company on www.sedar.com. The shares are also
subject to resale restrictions prescribed by the U.S. securities laws and
cannot be resold during the next 12 months and without strict compliance with
the U.S. securities laws.

We seek Safe Harbor.

For further
information please contact: John Affenita, Director & CEO

Phone: +1 (516) 680-0433

Neither the
CSE nor its Regulation Services Provider has reviewed or accepts responsibility
for the adequacy or accuracy of the contents of this news release.